Not sure when you jumped into bard DB but I got on board late 2017. The bard1 lung RUO kit had received ordinary results and BD1 seemed cheap considering the patents and technology that was still on the table. Not to mention costs were low and things were progressing.
Fast forward to the middle of 2020, i feel we've lost our way. The sdx arrangement still does not add up to me. SP is rooted even with a reasonable announcement yesterday. The SP has previously skyrocketed on less news than yesterday's. What held it back?
I'm still happy to hold a small amount in the hope we can pull off a sensational blood test for multiple cancers, but I'm very concerned about recently added costs and serious progress (or lack of), the only things that make or break a business.
Imo.
Not sure when you jumped into bard DB but I got on board late...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.005(0.90%) |
Mkt cap ! $62.03M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 57.0¢ | 55.5¢ | $20.17K | 35.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 20494 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 8700 | 1 |
View Market Depth
| Last trade - 15.57pm 03/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |